NICHOLAS ANZIDEO: Open Payments
NPI 1629441696 · NORTH WALES, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,158 in 56 payments from 9 companies in 2025. Trend: 2023 $988 · 2024 $1,513 · 2025 $1,158
Food & beverage: $1,148Education: $10
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 14 | $463 |
| ABBVIE INC. | 20 | $255 |
| GENZYME CORPORATION | 4 | $158 |
| Organon LLC | 9 | $108 |
| PFIZER INC. | 5 | $84 |
| Boston Scientific Corporation | 1 | $39 |
| Galderma Laboratories, L.P. | 1 | $17 |
| LEO Pharma Inc. | 1 | $17 |
| UCB, Inc. | 1 | $15 |
Products named: TREMFYA, DUPIXENT, SKYRIZI, RINVOQ, CIBINQO, AMS 700, AKLIEF, ANZUPGO.
Industry payments across PA — which companies pay providers there.
